86 related articles for article (PubMed ID: 29234114)
1. GW5074 and PP2 kinase inhibitors implicate nontraditional c-Raf and Lyn function as drivers of retinoic acid-induced maturation.
Jensen HA; Bunaciu RP; Varner JD; Yen A
Cell Signal; 2015 Aug; 27(8):1666-75. PubMed ID: 25817574
[TBL] [Abstract][Full Text] [Related]
2. Vitamin A and immune function: retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells.
Chen Q; Ross AC
Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14142-9. PubMed ID: 16093312
[TBL] [Abstract][Full Text] [Related]
3. HIV Disease Progression: Overexpression of the Ectoenzyme CD38 as a Contributory Factor?
Rodríguez-Alba JC; Abrego-Peredo A; Gallardo-Hernández C; Pérez-Lara J; Santiago-Cruz W; Jiang W; Espinosa E
Bioessays; 2019 Jan; 41(1):e1800128. PubMed ID: 30537007
[TBL] [Abstract][Full Text] [Related]
4. CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity.
Piedra-Quintero ZL; Wilson Z; Nava P; Guerau-de-Arellano M
Front Immunol; 2020; 11():597959. PubMed ID: 33329591
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-mediated deletion of a GA-repeat in human GPM6B leads to disruption of neural cell differentiation from NT2 cells.
Bayat H; Mirahmadi M; Azarshin Z; Ohadi H; Delbari A; Ohadi M
Sci Rep; 2024 Jan; 14(1):2136. PubMed ID: 38273037
[TBL] [Abstract][Full Text] [Related]
6. Evolving roles of CD38 metabolism in solid tumour microenvironment.
Gao L; Du X; Li J; Qin FX
Br J Cancer; 2023 Feb; 128(4):492-504. PubMed ID: 36396822
[TBL] [Abstract][Full Text] [Related]
7. Evidence of off-target effects of bosutinib that promote retinoic acid-induced differentiation of non-APL AML cells.
Kazim N; Yen A
Cell Cycle; 2021 Dec; 20(24):2638-2651. PubMed ID: 34836491
[TBL] [Abstract][Full Text] [Related]
8. Role for Fgr and Numb in retinoic acid-induced differentiation and G0 arrest of non-APL AML cells.
Kazim N; Yen A
Oncotarget; 2021 Jun; 12(12):1147-1164. PubMed ID: 34136084
[TBL] [Abstract][Full Text] [Related]
9. Depleting interferon regulatory factor-1(IRF-1) with CRISPR/Cas9 attenuates inducible oxidative metabolism without affecting RA-induced differentiation in HL-60 human AML cells.
Zhu K; Yue J; Yen A
FASEB Bioadv; 2020 Jun; 2(6):354-364. PubMed ID: 32617521
[TBL] [Abstract][Full Text] [Related]
10. Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting.
Viola D; Dona A; Caserta E; Troadec E; Besi F; McDonald T; Ghoda L; Gunes EG; Sanchez JF; Khalife J; Martella M; Karanes C; Htut M; Wang X; Rosenzweig M; Chowdhury A; Sborov D; Miles RR; Yazaki PJ; Ebner T; Hofmeister CC; Forman SJ; Rosen ST; Marcucci G; Shively J; Keats JJ; Krishnan A; Pichiorri F
Leukemia; 2021 Jan; 35(1):189-200. PubMed ID: 32296125
[TBL] [Abstract][Full Text] [Related]
11. Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets.
Vaisitti T; Arruga F; Guerra G; Deaglio S
Front Immunol; 2019; 10():2301. PubMed ID: 31636635
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid and 6-formylindolo(3,2-b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AML.
Bunaciu RP; MacDonald RJ; Jensen HA; Gao F; Wang X; Johnson L; Varner JD; Yen A
Leuk Lymphoma; 2019 Jul; 60(7):1697-1708. PubMed ID: 30570341
[TBL] [Abstract][Full Text] [Related]
13. CXCR5 overexpression in HL-60 cells enhances chemotaxis toward CXCL13 without anticipated interaction partners or enhanced MAPK signaling.
MacDonald RJ; Yen A
In Vitro Cell Dev Biol Anim; 2018 Dec; 54(10):725-735. PubMed ID: 30276608
[TBL] [Abstract][Full Text] [Related]
14. CD38/cADPR Signaling Pathway in Airway Disease: Regulatory Mechanisms.
Deshpande DA; Guedes AGP; Graeff R; Dogan S; Subramanian S; Walseth TF; Kannan MS
Mediators Inflamm; 2018; 2018():8942042. PubMed ID: 29576747
[TBL] [Abstract][Full Text] [Related]
15. Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cells.
MacDonald RJ; Bunaciu RP; Ip V; Dai D; Tran D; Varner JD; Yen A
Leuk Lymphoma; 2018 Dec; 59(12):2941-2951. PubMed ID: 29569971
[TBL] [Abstract][Full Text] [Related]
16. Probing the requirement for CD38 in retinoic acid-induced HL-60 cell differentiation with a small molecule dimerizer and genetic knockout.
MacDonald RJ; Shrimp JH; Jiang H; Zhang L; Lin H; Yen A
Sci Rep; 2017 Dec; 7(1):17406. PubMed ID: 29234114
[TBL] [Abstract][Full Text] [Related]
17. c-Cbl tyrosine kinase-binding domain mutant G306E abolishes the interaction of c-Cbl with CD38 and fails to promote retinoic acid-induced cell differentiation and G0 arrest.
Shen M; Yen A
J Biol Chem; 2009 Sep; 284(38):25664-77. PubMed ID: 19635790
[TBL] [Abstract][Full Text] [Related]
18. 6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells.
Bunaciu RP; Jensen HA; MacDonald RJ; LaTocha DH; Varner JD; Yen A
PLoS One; 2015; 10(8):e0135668. PubMed ID: 26287494
[TBL] [Abstract][Full Text] [Related]
19. ATRA-induced HL-60 myeloid leukemia cell differentiation depends on the CD38 cytosolic tail needed for membrane localization, but CD38 enzymatic activity is unnecessary.
Congleton J; Jiang H; Malavasi F; Lin H; Yen A
Exp Cell Res; 2011 Apr; 317(7):910-9. PubMed ID: 21156171
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
